nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—ABCB1—melanoma	0.706	1	CbGaD
Flupentixol—ADRA1A—Signaling Pathways—TERT—melanoma	2.72e-05	9.24e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—RAC1—melanoma	2.71e-05	9.22e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—KRAS—melanoma	2.71e-05	9.22e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HIF1A—melanoma	2.7e-05	9.18e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—HIF1A—melanoma	2.66e-05	9.03e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—FGF2—melanoma	2.65e-05	9.01e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HIF1A—melanoma	2.64e-05	8.98e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HIF1A—melanoma	2.6e-05	8.84e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—KDR—melanoma	2.58e-05	8.78e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—KDR—melanoma	2.54e-05	8.63e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—KDR—melanoma	2.53e-05	8.59e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—PIK3CA—melanoma	2.49e-05	8.47e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—KDR—melanoma	2.49e-05	8.46e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—FN1—melanoma	2.48e-05	8.45e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MDM2—melanoma	2.48e-05	8.43e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ERBB2—melanoma	2.45e-05	8.31e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—FN1—melanoma	2.45e-05	8.31e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—FN1—melanoma	2.43e-05	8.27e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—NOTCH1—melanoma	2.43e-05	8.27e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PIK3CB—melanoma	2.41e-05	8.2e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—FN1—melanoma	2.39e-05	8.14e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NOTCH1—melanoma	2.39e-05	8.13e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CD80—melanoma	2.38e-05	8.1e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NOTCH1—melanoma	2.38e-05	8.09e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—APC—melanoma	2.38e-05	8.08e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CG—melanoma	2.38e-05	8.08e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—KIT—melanoma	2.38e-05	8.08e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—NRAS—melanoma	2.38e-05	8.08e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—EGF—melanoma	2.35e-05	7.99e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CD80—melanoma	2.34e-05	7.97e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NOTCH1—melanoma	2.34e-05	7.96e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—APC—melanoma	2.34e-05	7.95e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—KIT—melanoma	2.34e-05	7.95e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CG—melanoma	2.34e-05	7.95e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—NRAS—melanoma	2.34e-05	7.95e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CD80—melanoma	2.33e-05	7.93e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CG—melanoma	2.33e-05	7.91e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—APC—melanoma	2.33e-05	7.91e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—KIT—melanoma	2.33e-05	7.91e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—NRAS—melanoma	2.33e-05	7.91e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CXCL8—melanoma	2.32e-05	7.88e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—EGF—melanoma	2.31e-05	7.86e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—HRAS—melanoma	2.3e-05	7.83e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—EGF—melanoma	2.3e-05	7.82e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CD80—melanoma	2.3e-05	7.8e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CG—melanoma	2.29e-05	7.79e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—APC—melanoma	2.29e-05	7.79e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—KIT—melanoma	2.29e-05	7.79e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—NRAS—melanoma	2.29e-05	7.79e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—MAPK3—melanoma	2.28e-05	7.74e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CDKN1B—melanoma	2.26e-05	7.7e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—EGF—melanoma	2.26e-05	7.7e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PRKCA—melanoma	2.25e-05	7.64e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—MAPK3—melanoma	2.24e-05	7.62e-05	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—AKT1—melanoma	2.24e-05	7.62e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—BRAF—melanoma	2.24e-05	7.6e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—ERCC2—melanoma	2.23e-05	7.58e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—MAPK3—melanoma	2.23e-05	7.58e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CASP3—melanoma	2.22e-05	7.55e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IL2—melanoma	2.22e-05	7.53e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—IL6—melanoma	2.21e-05	7.5e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—BRAF—melanoma	2.2e-05	7.48e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—MAPK3—melanoma	2.19e-05	7.46e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—BRAF—melanoma	2.19e-05	7.44e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IGF1—melanoma	2.18e-05	7.4e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—MAPK1—melanoma	2.17e-05	7.37e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—EGFR—melanoma	2.17e-05	7.37e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CCND1—melanoma	2.16e-05	7.35e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—BRAF—melanoma	2.15e-05	7.32e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IGF1—melanoma	2.14e-05	7.28e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CTNNB1—melanoma	2.14e-05	7.27e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—MAPK1—melanoma	2.13e-05	7.25e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—EGFR—melanoma	2.13e-05	7.25e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IGF1—melanoma	2.13e-05	7.24e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—MAPK1—melanoma	2.12e-05	7.21e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—EGFR—melanoma	2.12e-05	7.21e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MAP2K1—melanoma	2.1e-05	7.15e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IGF1—melanoma	2.1e-05	7.13e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MMP9—melanoma	2.1e-05	7.13e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CD—melanoma	2.09e-05	7.11e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CDKN1A—melanoma	2.09e-05	7.11e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—MAPK1—melanoma	2.09e-05	7.1e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—EGFR—melanoma	2.09e-05	7.1e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PTEN—melanoma	2.09e-05	7.09e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—NFKB1—melanoma	2.08e-05	7.06e-05	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—PIK3CA—melanoma	2.07e-05	7.04e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MAP2K1—melanoma	2.07e-05	7.04e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MAP2K1—melanoma	2.06e-05	7e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CD—melanoma	2.06e-05	6.99e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—KRAS—melanoma	2.05e-05	6.96e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CD—melanoma	2.05e-05	6.96e-05	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—PIK3CA—melanoma	2.04e-05	6.93e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—AKT1—melanoma	2.03e-05	6.92e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MAP2K1—melanoma	2.03e-05	6.89e-05	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—PIK3CA—melanoma	2.03e-05	6.89e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CD—melanoma	2.01e-05	6.85e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—KRAS—melanoma	2.01e-05	6.85e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—KRAS—melanoma	2e-05	6.81e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—FGF2—melanoma	2e-05	6.8e-05	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—PIK3CA—melanoma	2e-05	6.78e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—KRAS—melanoma	1.97e-05	6.7e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—FGF2—melanoma	1.97e-05	6.7e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—FGF2—melanoma	1.96e-05	6.66e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—FGF2—melanoma	1.93e-05	6.56e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—VEGFA—melanoma	1.88e-05	6.4e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—PIK3CA—melanoma	1.88e-05	6.39e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MDM2—melanoma	1.87e-05	6.37e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—STAT3—melanoma	1.87e-05	6.34e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—NRAS—melanoma	1.86e-05	6.33e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—PIK3CA—melanoma	1.85e-05	6.29e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ERBB2—melanoma	1.85e-05	6.28e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MDM2—melanoma	1.84e-05	6.26e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—PIK3CA—melanoma	1.84e-05	6.26e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MDM2—melanoma	1.83e-05	6.23e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CB—melanoma	1.82e-05	6.19e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ERBB2—melanoma	1.82e-05	6.18e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—PIK3CA—melanoma	1.81e-05	6.16e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ERBB2—melanoma	1.81e-05	6.14e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MDM2—melanoma	1.8e-05	6.13e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CB—melanoma	1.79e-05	6.1e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CB—melanoma	1.78e-05	6.06e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MAPK3—melanoma	1.78e-05	6.06e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ERBB2—melanoma	1.78e-05	6.05e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CG—melanoma	1.76e-05	5.98e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CB—melanoma	1.76e-05	5.97e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CXCL8—melanoma	1.75e-05	5.95e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—HRAS—melanoma	1.74e-05	5.91e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MYC—melanoma	1.73e-05	5.89e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CXCL8—melanoma	1.72e-05	5.86e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CXCL8—melanoma	1.71e-05	5.83e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—HRAS—melanoma	1.71e-05	5.82e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CDKN1B—melanoma	1.71e-05	5.81e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—HRAS—melanoma	1.7e-05	5.79e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PPARG—melanoma	1.7e-05	5.78e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MAPK1—melanoma	1.7e-05	5.76e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—EGFR—melanoma	1.7e-05	5.76e-05	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—AKT1—melanoma	1.69e-05	5.75e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CXCL8—melanoma	1.69e-05	5.74e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CDKN1B—melanoma	1.68e-05	5.72e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—HRAS—melanoma	1.68e-05	5.7e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CASP3—melanoma	1.68e-05	5.7e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CDKN1B—melanoma	1.67e-05	5.69e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IL2—melanoma	1.67e-05	5.69e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—IL6—melanoma	1.67e-05	5.66e-05	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—AKT1—melanoma	1.66e-05	5.66e-05	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—AKT1—melanoma	1.66e-05	5.63e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CASP3—melanoma	1.65e-05	5.61e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CDKN1B—melanoma	1.65e-05	5.6e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IL2—melanoma	1.65e-05	5.6e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CASP3—melanoma	1.64e-05	5.58e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—IL6—melanoma	1.64e-05	5.57e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IL2—melanoma	1.64e-05	5.57e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CCND1—melanoma	1.63e-05	5.55e-05	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—AKT1—melanoma	1.63e-05	5.54e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—IL6—melanoma	1.63e-05	5.54e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CTNNB1—melanoma	1.62e-05	5.49e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CASP3—melanoma	1.61e-05	5.49e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IL2—melanoma	1.61e-05	5.48e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CCND1—melanoma	1.61e-05	5.46e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—IL6—melanoma	1.6e-05	5.45e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—KRAS—melanoma	1.6e-05	5.44e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CCND1—melanoma	1.6e-05	5.43e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CTNNB1—melanoma	1.59e-05	5.4e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MMP9—melanoma	1.58e-05	5.38e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CTNNB1—melanoma	1.58e-05	5.37e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CDKN1A—melanoma	1.58e-05	5.36e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PTEN—melanoma	1.57e-05	5.35e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CCND1—melanoma	1.57e-05	5.34e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—NFKB1—melanoma	1.57e-05	5.33e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MMP9—melanoma	1.56e-05	5.3e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CTNNB1—melanoma	1.56e-05	5.29e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CDKN1A—melanoma	1.55e-05	5.28e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MMP9—melanoma	1.55e-05	5.27e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PTEN—melanoma	1.55e-05	5.27e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CD—melanoma	1.55e-05	5.26e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CDKN1A—melanoma	1.54e-05	5.25e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NFKB1—melanoma	1.54e-05	5.24e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PTEN—melanoma	1.54e-05	5.24e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—AKT1—melanoma	1.54e-05	5.22e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NFKB1—melanoma	1.53e-05	5.21e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—ALB—melanoma	1.53e-05	5.19e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MMP9—melanoma	1.53e-05	5.19e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CDKN1A—melanoma	1.52e-05	5.17e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PTEN—melanoma	1.52e-05	5.16e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—AKT1—melanoma	1.51e-05	5.14e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NFKB1—melanoma	1.51e-05	5.13e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—AKT1—melanoma	1.5e-05	5.11e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—AKT1—melanoma	1.48e-05	5.03e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PIK3CA—melanoma	1.47e-05	5e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TP53—melanoma	1.42e-05	4.84e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—VEGFA—melanoma	1.42e-05	4.83e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—STAT3—melanoma	1.41e-05	4.79e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—NRAS—melanoma	1.4e-05	4.78e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—VEGFA—melanoma	1.4e-05	4.76e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—VEGFA—melanoma	1.39e-05	4.73e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—STAT3—melanoma	1.39e-05	4.71e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NRAS—melanoma	1.38e-05	4.7e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—STAT3—melanoma	1.38e-05	4.69e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NRAS—melanoma	1.37e-05	4.67e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—VEGFA—melanoma	1.37e-05	4.66e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—HRAS—melanoma	1.36e-05	4.63e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—STAT3—melanoma	1.36e-05	4.61e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NRAS—melanoma	1.35e-05	4.6e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CB—melanoma	1.35e-05	4.59e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MAPK3—melanoma	1.35e-05	4.57e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PTGS2—melanoma	1.34e-05	4.54e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MAPK3—melanoma	1.32e-05	4.5e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MAPK3—melanoma	1.32e-05	4.48e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MYC—melanoma	1.31e-05	4.45e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IL6—melanoma	1.3e-05	4.43e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MAPK3—melanoma	1.3e-05	4.41e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MYC—melanoma	1.29e-05	4.38e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MYC—melanoma	1.28e-05	4.35e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MAPK1—melanoma	1.28e-05	4.35e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—EGFR—melanoma	1.28e-05	4.35e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MYC—melanoma	1.26e-05	4.29e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MAPK1—melanoma	1.26e-05	4.28e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—EGFR—melanoma	1.26e-05	4.28e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MAPK1—melanoma	1.25e-05	4.26e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—EGFR—melanoma	1.25e-05	4.26e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MAPK1—melanoma	1.23e-05	4.19e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—EGFR—melanoma	1.23e-05	4.19e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—KRAS—melanoma	1.21e-05	4.11e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—AKT1—melanoma	1.2e-05	4.09e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—KRAS—melanoma	1.19e-05	4.04e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—KRAS—melanoma	1.18e-05	4.02e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PTEN—melanoma	1.17e-05	3.96e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—KRAS—melanoma	1.16e-05	3.96e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CA—melanoma	1.11e-05	3.78e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CA—melanoma	1.09e-05	3.72e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CA—melanoma	1.09e-05	3.7e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TP53—melanoma	1.07e-05	3.65e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CA—melanoma	1.07e-05	3.64e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TP53—melanoma	1.06e-05	3.59e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TP53—melanoma	1.05e-05	3.58e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TP53—melanoma	1.04e-05	3.52e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HRAS—melanoma	1.03e-05	3.49e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—HRAS—melanoma	1.01e-05	3.44e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HRAS—melanoma	1.01e-05	3.42e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HRAS—melanoma	9.9e-06	3.37e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IL6—melanoma	9.84e-06	3.34e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IL6—melanoma	9.68e-06	3.29e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IL6—melanoma	9.63e-06	3.27e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IL6—melanoma	9.48e-06	3.22e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—AKT1—melanoma	9.07e-06	3.08e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—AKT1—melanoma	8.93e-06	3.04e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—AKT1—melanoma	8.88e-06	3.02e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—AKT1—melanoma	8.74e-06	2.97e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CA—melanoma	8.22e-06	2.8e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—AKT1—melanoma	6.72e-06	2.28e-05	CbGpPWpGaD
